-
Chronic kidney disease associated pruritus and healthcare resource utilization in European hemodialysis patients: results from an electronic patient-reported outcome survey
Fotheringham, J., Tu, C., Pisoni, R. L., Fuller, S., Schaufler, T., Ruessmann, D., Vervloet, M. G., Pecoits-Filho, R. & Karaboyas, A., 1 Dec 2026, In: BMC Nephrology. 27, 1, 1.Research output: Contribution to Journal › Article › Academic › peer-review
-
Calciprotein crystallization time (T50) and its association with surrogate cardiovascular disease risk markers in individuals with type 2 diabetes mellitus: the cross-sectional EARLY-HFpEF study
Meer, R., Hoek, A. G., Dal Canto, E., Doesburg, T., Pasch, A., Vervloet, M. G., de Jong, P. A., Elders, P. J. M. & Beulens, J. W. J., Dec 2026, In: Cardiovascular Diabetology. 25, 1, 10.Research output: Contribution to Journal › Article › Academic › peer-review
-
Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions
Kopytina, V., Marchant, V., Rodrigues-Diez, R., Pascual-Antón, L., Toggweiler, N., Strahl, L., Kane, J., Tejera-Muñoz, A., Cortés, M., Sucunza, D., Vaquero, J. J., Vervloet, M., Piecha, D., Eringa, E. C., Ruiz-Ortega, M., lópez-Cabrera, M. & González-Mateo, G. T., 1 Jun 2026, In: Nephrology dialysis transplantation. 41, 6, p. 1147-1160 14 p.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
